Cooper Companies | COO - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.69M 193K 2026-06
AtriCure USD 394K 1.97M 2026-03
Bausch Health Companies USD 348M 1.7B 2026-06
Baxter International USD 362M 368M 2026-06
Bayer EUR 321M 2.67B 2026-06
Becton, Dickinson and Co. USD 39M 354M 2026-03
Boston Scientific USD 1.42B 261M 2026-06
Cooper Companies USD -48.4M 240.6M 2026-03
Dentsply International USD -42M 105M 2026-03
Dexcom USD 269.5M 71.2M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Globus Medical USD 157.07M 12.16M 2026-03
Haemonetics USD 47.57M 75.97M 2026-06
Inogen USD -6.06M 467K 2024-09
Insulet USD 118.7M 5.7M 2026-06
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 940.4M 15.2M 2026-03
J&J USD 7.67B 988M 2026-09
Medtronic USD 2.26B 190M 2026-06
Merit Medical Systems USD 53.55M 2.49M 2026-03
Novartis USD 3.84B 1.33B 2026-03
ResMed USD 502.31M 6.16M 2026-03
STAAR Surgical USD 8.22M 28.87M 2026-03
Steris USD 304.5M 46.7M 2026-03
Stryker USD 850M 855M 2026-03
Tandem Diabetes Care USD -19.88M 24.56M 2026-03
Teleflex USD -3.83M 222.77M 2026-03
Utah Medical Products 418K 3K 2024-09
Zimmer Biomet Holdings USD 487.5M 186.2M 2026-06